Last update : 02/03/2021 | Version : 1 | ID : 73649
| General | |
| Identification | |
| Detailed name | Hospitalization or Outpatient ManagEment of patients with a proven or probable SARS-CoV-2 infection | 
| Sign or acronym | HOME-CoV | 
| General Aspects | |
| Medical area | 			
							Emergency medicine | 
		
| Study in connection with Covid-19 | 			
				Yes | 
		
| Health determinants | 			
							Healthcare system and access to health care services | 
		
| Keywords | COVID-19; Hospitalization; Outpatient; Rule validation; Expert consensus; Rule-based decision-making; Clinical support decision tool. | 
| Scientific investigator(s) (Contact) | |
| Name of the director | DOUILLET | 
| Surname | Delphine | 
| Delphine.Douillet@chu-angers.fr | |
| Collaborations | |
| Funding | |
| Funding status | 			
					Public | 
		
| Details | CHU Angers | 
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | CHU Angers | 
| Organisation status | |
| Additional contact | |
| loic.carballido@chu-angers.fr | |
| Main features | |
| Type of database | |
| Type of database | 			
							Study databases | 
		
| Study databases (details) | 			
							Cohort study | 
		
| Database recruitment is carried out by an intermediary | 			
					A selection of health institutions and services | 
		
| Database recruitment is is made on the basis of: | 			
					Another treatment or procedure | 
		
| Database recruitment is carried out as part of an interventional study | 			
				Yes | 
		
| Details | 			
					Performed at group level (clusters) | 
		
| Database objective | |
| Main objective | 			
				
the composite rate of adverse outcomes [ Time Frame: day 7 ]
 Adverse outcomes include intubation with mechanical ventilation requirement and death (Stage ≥ 6 on "Ordinal Scale for Clinical Improvement" of the World Health Organization) within 7 days after inclusion.  | 
		
| Inclusion criteria | 			
				
The rate of hospitalization [ Time Frame: 24 hours ]
 The rate of patients hospitalized after admission to the emergency room including patients discharged home more than 24 hours after admission. It will be analyzed in a hierarchical approach, only if first primary objective is positive i.e. non-inferiority of HOME-CoV strategy versus current practice on the rate of adverse outcomes.  | 
		
| Population type | |
| Age | 			
					Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more)  | 
		
| Population covered | 			
					Sick population | 
		
| Pathology | J12 - Viral pneumonia, not elsewhere classified | 
| Gender | 			
					Male Woman  | 
		
| Geography area | 			
					International | 
		
| Detail of the geography area | France Belgium | 
| Data collection | |
| Dates | |
| Size of the database | |
| Size of the database (number of individuals) | 			
					[1000-10 000[ individuals | 
		
| Details of the number of individuals | 4000 | 
| Data | |
| Database activity | 			
					Current data collection | 
		
| Type of data collected | 			
					Clinical data Declarative data Paraclinical data Biological data Administrative data  | 
		
| Clinical data (detail) | 			
					Direct physical measures Medical registration  | 
		
| Declarative data (detail) | 			
					Face to face interview Phone interview  | 
		
| Procedures | |
| Participant monitoring | 			
				Yes | 
		
| Monitoring procedures | 			
					Monitoring by contact with the participant (mail, e-mail, telephone etc.) | 
		
| Promotion and access | |
| Promotion | |
| Access | 
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05